The analysis of diabetes medicine use in Germany shows a steady upward trend. Between 2013 and 2023, the consumption increased from 83.2 Units (Defined Daily Dosage) Per Thousand Persons Per Day to 97.8. Year-on-year variations display fluctuations, with notable peaks such as a 3.06% rise in 2020, highlighting increasing medicine usage. The CAGR over the last five years is 2.63%, indicating strong growth in this period. Forecasts from 2024 to 2028 project continued growth, albeit at a slower CAGR of 1.04%, reaching 104.9 units by 2028.
Future trends to watch for include:
- Advancements in diabetes management technologies and therapies.
- Potential impact of public health initiatives on diabetes prevention and care.
- Emergence of new medications that could influence consumption patterns.
- Changes in healthcare policy and funding affecting access to diabetes treatment.
